JUMPCAN's subsidiary has obtained the drug registration certificate for lidocaine gel patches

Zhitong
2025.09.16 08:35
portai
I'm PortAI, I can summarize articles.

According to the Zhitong Finance APP, JUMPCAN announced that its wholly-owned subsidiary Shaanxi Dongke Pharmaceutical Co., Ltd. (referred to as "Shaanxi Dongke") has received the drug registration certificate for lidocaine gel patch approved and issued by the National Medical Products Administration. Lidocaine is an amide-type local anesthetic that stabilizes nerve cell membranes by inhibiting the ion channels required for the generation and conduction of nerve impulses

According to the Zhitong Finance APP, JUMPCAN (600566.SH) announced that its wholly-owned subsidiary Shaanxi Dongke Pharmaceutical Co., Ltd. (referred to as "Shaanxi Dongke") has received the drug registration certificate for lidocaine gel patch approved by the National Medical Products Administration. Lidocaine is an amide-type local anesthetic that stabilizes nerve cell membranes by inhibiting the ion channels required for the generation and conduction of nerve impulses

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer